Email Alert | RSS

  • AIMS AND SCOPE

    Chinese Journal of Antituberculosis is published monthly in Chinese by the Chinese Antituberculosis Association, and is a peer reviewed medical journal for doctors, medical researchers, and health workers in the field of tuberculosis. The journal reports the advances and progress in current tuberculosis sciences and technology.


    Scope of the journal

    Chinese Journal of Antituberculosis provides a medium for the publication of original research and development work in the field of tuberculosis prevention and treatment. Chinese Journal of Antituberculosis seeks papers in the following topics.

    Study on tuberculosis control strategy;

    Epidemiological study on tuberculosis;

    Study on diagnostic technology of tuberculosis;

    Study on Pathogenic Mechanism of Mycobacterium Tuberculosis;

    Study on drug resistance mechanism of mycobacterium tuberculosis;

    Study on treatment strategy of tuberculosis;

    Research on tuberculosis drugs;

    Study on drug treatment scheme of tuberculosis;

    Research on tuberculosis vaccine;

    Study on differential diagnosis of tuberculosis;

    Study on the comorbidity of tuberculosis and other diseases;

    Study on Pathogenic Mechanism of nontuberculous mycobacterium;

    Study on drug resistance mechanism of nontuberculous mycobacterium;

    Study on treatment strategy of nontuberculous mycobacterial disease

     

    MANUSCRIPT CATEGORIES AND REQUIREMENTS

    (1) Editorial Commentary
    Word Limit: 1500 words maximum. Abstract: not required.

    Description: Proposals for Editorial Commentary may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

    (2) Review

    Word limit: 5000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, unstructured (no use of sub-headers). References: no limit.

    Description: Review should not simply summarize information, but also discuss the importance and impact of the data providing a clear view on how these insights have transformed or will transform the field. Authors of review articles are encouraged to include several figures and tables to summarize and visualize data.

    (3) Meta Analysis

    Word limit: 4000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, with sub-headers. References: no limit. Figures/tables: no limit.
    Description: Meta analysis articles could be submitted by any author and are composed of a systematic review, mixed treatment compariaon, meta-regression and overview of reviews and provide a summary of a given quantitative effect.

    (4) Original Article

    Word limit: 4000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, with sub-headers. References: no limit. Figures/tables: no limit.

    Description: Full-length reports of current research in either basic or clinical science.

    (5) Brief Report

    Word limit: 1500 words excluding references, tables and figures. Abstract: Not required. Keywords: Not required. References: 35 maximum. Figures/tables: 4 maximum in total.


    PREPARING THE SUBMISSION

    Style of the Manuscript

    Manuscripts must follow the style detailed in the International Committee of Medical Journal Editors’ revised Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication.

    Format You could prepare the main text file using Microsoft Word without worrying about formatting requirements.

    Units All measurements must be given in SI or SI-derived units. For more information about SI units, please go to the Bureau International des Poids et Mesures (BIPM) website at: http://www.bipm.fr/

    Abbreviations Must be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

    Trade names Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.

    Parts of the Manuscript

    The manuscript should be submitted in separate files: title page; main text file; figures; and supplementary files if required. Chinese Journal of Antituberculosis uses double-blind peer review. To facilitate this, please include the following separately:

    Title page (with author details): This should include the title, authors' names, affiliations, acknowledgements and any Declaration of Interest statement, and a complete address for the corresponding author including an e-mail address.
    Anonymized manuscript (no author details): The main body of the paper (including the references, figures, tables and any acknowledgements) should not include any identifying information, such as the authors' names or affiliations.


    Title Page File
    The title page should contain:

    i. The title and running title (less than 40 characters) of the paper. Concise titles are easier to read than long, convoluted ones. Titles that are too short may, however, lack important information, such as study design (which is particularly important in identifying randomized controlled trials). Authors should include all information in the title that will make electronic retrieval of the article both sensitive and specific.
    ii. The full names of the authors;
    iii. The addresses of the institutions at which the work was carried out (the present address of any author, if different from that where the work was carried out, should be supplied in a footnote);
    iv. The full postal and email address, plus telephone numbers, of the author to whom correspondence about the manuscript should be sent.


    Author name

    Each author’s given name should be followed by family name. 

    Hyphens can be used in the family name according to the rules use in the author's region.

    Capitalize the first letter of those words/syllables that they hope to be abbreviated in their given name, otherwise, DO NOT capitalize the first letter and use a hyphen to connect it with its anterior word.


    Main Text File

    The main text file should be presented in the following order:

    i. Title;
    ii. Abstract;
    iii. Key points;
    iv. Key words;
    v. Text;
    vi. Acknowledgments;
    vii. Disclosure;
    viii. Data availability;
    ix. References;
    x. Tables (each table complete with title and footnotes);
    xi. Figure legends.

    Figures and supplementary material should be supplied as separate files.

    Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.


    Abstract

    The length of abstracts must adhere to the word count specifications under the section Manuscript Categories. The abstract should state the main problem, methods, results, and conclusions. It must be factual and comprehensive. The use of abbreviations and acronyms should be limited and general statements (e.g. 'the significance of the results is discussed') should be avoided.


    Key words

    Three to five key words should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) .


    Text

    Authors should use the subheadings required for the Article Type as specified in the section 'Manuscript Categories'. Original Article manuscripts should be structured using the following sections: Objective, Methods, Results, Discussion.


    Acknowledgements

    This should include sources of support/funding, including federal and industry support. All authors who have contributed to the manuscript must be acknowledged any federal and industry support/funding received. Medical writers, proofreaders and editors should not be listed as authors, but acknowledged here in the acknowledgements section.


    Disclosure

    Articles are required to include a disclosure statement. The statement should disclose all potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript. Authors without conflicts of interest should include a statement of no such interests in the Disclosure section of the manuscript. Failure to include this information in the manuscript may delay evaluation and review of the manuscript.
    Especially, for an article authorized by editorial board including Editor-in-Chief, Associate Editors, Editorial Board Members and Advisory Board Members, the statement "Professor xx is a member of Chinese Journal of Antituberculosis editorial board and is not involved in the peer review process of this article" should be disclosed.


    References

    All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. Journal titles are abbreviated; abbreviations may be found in the following: MEDLINE , Index Medicus , or CalTech Library 


    Tables

    Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Statistical measures such as SD or SEM should be identified in the headings.


    Figure legends

    Type figure legends on a separate page after References or Tables if the manuscript includes them. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.


    Figures

    All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Magnifications should be indicated using a scale bar on the illustration.

    Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

  • 2011-08-31   Visited: 13402

Monthly, Established in Novembar 1934
ISSN 1000-6621
CN 11-2761/R

    Responsible Institution
    China Association for Science and Technology
    Sponsor
    Chinese Antituberculosis Association
    42 Dongsi Xidajie,Beijing 100710,China
    Editing
    Editorial Board of Chinese Journal of Antituberculosis
    5 Dongguang Hutong,Beijing 100035,China
    Tel(Fax): 0086-10-62257587
    http://www.zgflzz.cn
    Email: zgfIzz@163.com
    Editor-in-chief
    WANG Li-xia(王黎霞)
    Managing Director
    Ll Jing-wen(李敬文)
    Publishing
    Chinese Journal of Antituberculosis Publishing House
    5 Dongguang Hutong, Beijing 100035,China
    Tel(Fax):0086-10-62257257
    Email: zgflzz@163.com
    Printing
    Tomato Cloud Printing (Cangzhou) Co., Ltd.
    Overseas Distributor
    China International BookTrading Corporation
    P.O. Box 399,Beijing 100044,China
    Code No.M3721
Wechat